Laura Lovett

The test was designed to identify specific antibodies in order to detect if a patient has had coronavirus in the past. 

The seat can collect data on a patient's heart rate, blood pressure, cardiac output, ECG and blood oxygenation. 

Also Cue Health scores $13 million from the department of Health and Human Services Biomedical Advanced Research and Development authority in order to fund its portable COVID-19 diagnostic test.

The round was led by Mosaik Partners, and will be used to grow PatientPay's product line. 

The round was led by Cigna Ventures and MemorialCare Innovation Fund with participation from Avalon Ventures, CU Healthcare Innovation Fund and Stanford Health Care. 

Users can choose from 100 conditions and get information about telemedicine pricing and medication services. 

This builds on a $500,000 dollar seed round announced last May. 

The new website and app were born out of a partnership with Apple, the CDC, the White House Coronavirus Task Force and FEMA.

CU Healthcare Innovation Fund led the Series A round. 

Yesterday MassChallenge hosted a summit on innovation in the age of the coronavirus crisis, and panelists discussed how providers are implementing new digital programs into their toolbox.